nodes	percent_of_prediction	percent_of_DWPC	metapath
Pregabalin—SLC1A1—prostate gland—urinary bladder cancer	0.0196	0.219	CbGeAlD
Pregabalin—SLC1A1—renal system—urinary bladder cancer	0.0134	0.149	CbGeAlD
Pregabalin—SLC1A1—female reproductive system—urinary bladder cancer	0.0107	0.12	CbGeAlD
Pregabalin—CACNA2D1—prostate gland—urinary bladder cancer	0.0102	0.114	CbGeAlD
Pregabalin—SLC1A1—vagina—urinary bladder cancer	0.00967	0.108	CbGeAlD
Pregabalin—CACNA2D2—vagina—urinary bladder cancer	0.00697	0.0779	CbGeAlD
Pregabalin—SLC1A1—lymph node—urinary bladder cancer	0.00626	0.0699	CbGeAlD
Pregabalin—CACNA2D1—vagina—urinary bladder cancer	0.00502	0.0561	CbGeAlD
Pregabalin—CACNA2D2—lymph node—urinary bladder cancer	0.00451	0.0504	CbGeAlD
Pregabalin—CACNA2D1—lymph node—urinary bladder cancer	0.00324	0.0363	CbGeAlD
Pregabalin—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000188	0.000206	CcSEcCtD
Pregabalin—Urethral disorder—Epirubicin—urinary bladder cancer	0.000188	0.000206	CcSEcCtD
Pregabalin—Epistaxis—Doxorubicin—urinary bladder cancer	0.000186	0.000204	CcSEcCtD
Pregabalin—Angiopathy—Methotrexate—urinary bladder cancer	0.000185	0.000204	CcSEcCtD
Pregabalin—Sinusitis—Doxorubicin—urinary bladder cancer	0.000185	0.000203	CcSEcCtD
Pregabalin—Immune system disorder—Methotrexate—urinary bladder cancer	0.000185	0.000203	CcSEcCtD
Pregabalin—Dizziness—Fluorouracil—urinary bladder cancer	0.000185	0.000203	CcSEcCtD
Pregabalin—Visual impairment—Epirubicin—urinary bladder cancer	0.000184	0.000202	CcSEcCtD
Pregabalin—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000184	0.000202	CcSEcCtD
Pregabalin—Chills—Methotrexate—urinary bladder cancer	0.000183	0.000201	CcSEcCtD
Pregabalin—Diarrhoea—Cisplatin—urinary bladder cancer	0.000181	0.000199	CcSEcCtD
Pregabalin—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000181	0.000199	CcSEcCtD
Pregabalin—Alopecia—Methotrexate—urinary bladder cancer	0.000181	0.000198	CcSEcCtD
Pregabalin—Vomiting—Gemcitabine—urinary bladder cancer	0.000181	0.000198	CcSEcCtD
Pregabalin—Bradycardia—Doxorubicin—urinary bladder cancer	0.00018	0.000198	CcSEcCtD
Pregabalin—Mental disorder—Methotrexate—urinary bladder cancer	0.000179	0.000197	CcSEcCtD
Pregabalin—Rash—Gemcitabine—urinary bladder cancer	0.000179	0.000197	CcSEcCtD
Pregabalin—Dermatitis—Gemcitabine—urinary bladder cancer	0.000179	0.000196	CcSEcCtD
Pregabalin—Eye disorder—Epirubicin—urinary bladder cancer	0.000179	0.000196	CcSEcCtD
Pregabalin—Hypersensitivity—Etoposide—urinary bladder cancer	0.000179	0.000196	CcSEcCtD
Pregabalin—Tinnitus—Epirubicin—urinary bladder cancer	0.000178	0.000196	CcSEcCtD
Pregabalin—Malnutrition—Methotrexate—urinary bladder cancer	0.000178	0.000195	CcSEcCtD
Pregabalin—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000178	0.000195	CcSEcCtD
Pregabalin—Headache—Gemcitabine—urinary bladder cancer	0.000178	0.000195	CcSEcCtD
Pregabalin—Flushing—Epirubicin—urinary bladder cancer	0.000178	0.000195	CcSEcCtD
Pregabalin—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000178	0.000195	CcSEcCtD
Pregabalin—Vomiting—Fluorouracil—urinary bladder cancer	0.000177	0.000195	CcSEcCtD
Pregabalin—Rhinitis—Doxorubicin—urinary bladder cancer	0.000177	0.000195	CcSEcCtD
Pregabalin—Hepatitis—Doxorubicin—urinary bladder cancer	0.000177	0.000194	CcSEcCtD
Pregabalin—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000177	0.000194	CcSEcCtD
Pregabalin—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000176	0.000193	CcSEcCtD
Pregabalin—Rash—Fluorouracil—urinary bladder cancer	0.000176	0.000193	CcSEcCtD
Pregabalin—Dermatitis—Fluorouracil—urinary bladder cancer	0.000176	0.000193	CcSEcCtD
Pregabalin—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000176	0.000193	CcSEcCtD
Pregabalin—Headache—Fluorouracil—urinary bladder cancer	0.000175	0.000192	CcSEcCtD
Pregabalin—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000175	0.000192	CcSEcCtD
Pregabalin—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000174	0.000191	CcSEcCtD
Pregabalin—Dysgeusia—Methotrexate—urinary bladder cancer	0.000174	0.000191	CcSEcCtD
Pregabalin—Asthenia—Etoposide—urinary bladder cancer	0.000174	0.000191	CcSEcCtD
Pregabalin—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000174	0.000191	CcSEcCtD
Pregabalin—Angiopathy—Epirubicin—urinary bladder cancer	0.000174	0.000191	CcSEcCtD
Pregabalin—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000173	0.000191	CcSEcCtD
Pregabalin—Immune system disorder—Epirubicin—urinary bladder cancer	0.000173	0.00019	CcSEcCtD
Pregabalin—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000172	0.000189	CcSEcCtD
Pregabalin—Back pain—Methotrexate—urinary bladder cancer	0.000172	0.000189	CcSEcCtD
Pregabalin—Chills—Epirubicin—urinary bladder cancer	0.000172	0.000189	CcSEcCtD
Pregabalin—Pruritus—Etoposide—urinary bladder cancer	0.000172	0.000188	CcSEcCtD
Pregabalin—Arrhythmia—Epirubicin—urinary bladder cancer	0.000171	0.000188	CcSEcCtD
Pregabalin—Visual impairment—Doxorubicin—urinary bladder cancer	0.000171	0.000187	CcSEcCtD
Pregabalin—Alopecia—Epirubicin—urinary bladder cancer	0.000169	0.000186	CcSEcCtD
Pregabalin—Nausea—Gemcitabine—urinary bladder cancer	0.000169	0.000185	CcSEcCtD
Pregabalin—Vomiting—Cisplatin—urinary bladder cancer	0.000168	0.000185	CcSEcCtD
Pregabalin—Vision blurred—Methotrexate—urinary bladder cancer	0.000168	0.000184	CcSEcCtD
Pregabalin—Mental disorder—Epirubicin—urinary bladder cancer	0.000168	0.000184	CcSEcCtD
Pregabalin—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000167	0.000184	CcSEcCtD
Pregabalin—Rash—Cisplatin—urinary bladder cancer	0.000167	0.000183	CcSEcCtD
Pregabalin—Dermatitis—Cisplatin—urinary bladder cancer	0.000167	0.000183	CcSEcCtD
Pregabalin—Malnutrition—Epirubicin—urinary bladder cancer	0.000167	0.000183	CcSEcCtD
Pregabalin—Diarrhoea—Etoposide—urinary bladder cancer	0.000166	0.000182	CcSEcCtD
Pregabalin—Nausea—Fluorouracil—urinary bladder cancer	0.000166	0.000182	CcSEcCtD
Pregabalin—Eye disorder—Doxorubicin—urinary bladder cancer	0.000165	0.000182	CcSEcCtD
Pregabalin—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000165	0.000181	CcSEcCtD
Pregabalin—Tinnitus—Doxorubicin—urinary bladder cancer	0.000165	0.000181	CcSEcCtD
Pregabalin—Anaemia—Methotrexate—urinary bladder cancer	0.000164	0.000181	CcSEcCtD
Pregabalin—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000164	0.00018	CcSEcCtD
Pregabalin—Flushing—Doxorubicin—urinary bladder cancer	0.000164	0.00018	CcSEcCtD
Pregabalin—Flatulence—Epirubicin—urinary bladder cancer	0.000164	0.00018	CcSEcCtD
Pregabalin—Tension—Epirubicin—urinary bladder cancer	0.000163	0.000179	CcSEcCtD
Pregabalin—Dysgeusia—Epirubicin—urinary bladder cancer	0.000163	0.000179	CcSEcCtD
Pregabalin—Nervousness—Epirubicin—urinary bladder cancer	0.000162	0.000178	CcSEcCtD
Pregabalin—Back pain—Epirubicin—urinary bladder cancer	0.000161	0.000177	CcSEcCtD
Pregabalin—Angiopathy—Doxorubicin—urinary bladder cancer	0.000161	0.000176	CcSEcCtD
Pregabalin—Malaise—Methotrexate—urinary bladder cancer	0.00016	0.000176	CcSEcCtD
Pregabalin—Dizziness—Etoposide—urinary bladder cancer	0.00016	0.000176	CcSEcCtD
Pregabalin—Muscle spasms—Epirubicin—urinary bladder cancer	0.00016	0.000176	CcSEcCtD
Pregabalin—Immune system disorder—Doxorubicin—urinary bladder cancer	0.00016	0.000176	CcSEcCtD
Pregabalin—Vertigo—Methotrexate—urinary bladder cancer	0.00016	0.000176	CcSEcCtD
Pregabalin—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.00016	0.000175	CcSEcCtD
Pregabalin—Leukopenia—Methotrexate—urinary bladder cancer	0.000159	0.000175	CcSEcCtD
Pregabalin—Chills—Doxorubicin—urinary bladder cancer	0.000159	0.000174	CcSEcCtD
Pregabalin—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000158	0.000174	CcSEcCtD
Pregabalin—Nausea—Cisplatin—urinary bladder cancer	0.000157	0.000173	CcSEcCtD
Pregabalin—Vision blurred—Epirubicin—urinary bladder cancer	0.000157	0.000172	CcSEcCtD
Pregabalin—Alopecia—Doxorubicin—urinary bladder cancer	0.000156	0.000172	CcSEcCtD
Pregabalin—Cough—Methotrexate—urinary bladder cancer	0.000155	0.000171	CcSEcCtD
Pregabalin—Mental disorder—Doxorubicin—urinary bladder cancer	0.000155	0.00017	CcSEcCtD
Pregabalin—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000154	0.00017	CcSEcCtD
Pregabalin—Convulsion—Methotrexate—urinary bladder cancer	0.000154	0.000169	CcSEcCtD
Pregabalin—Vomiting—Etoposide—urinary bladder cancer	0.000154	0.000169	CcSEcCtD
Pregabalin—Malnutrition—Doxorubicin—urinary bladder cancer	0.000154	0.000169	CcSEcCtD
Pregabalin—Anaemia—Epirubicin—urinary bladder cancer	0.000154	0.000169	CcSEcCtD
Pregabalin—Agitation—Epirubicin—urinary bladder cancer	0.000153	0.000168	CcSEcCtD
Pregabalin—Rash—Etoposide—urinary bladder cancer	0.000153	0.000168	CcSEcCtD
Pregabalin—Dermatitis—Etoposide—urinary bladder cancer	0.000153	0.000168	CcSEcCtD
Pregabalin—Headache—Etoposide—urinary bladder cancer	0.000152	0.000167	CcSEcCtD
Pregabalin—Flatulence—Doxorubicin—urinary bladder cancer	0.000152	0.000167	CcSEcCtD
Pregabalin—Myalgia—Methotrexate—urinary bladder cancer	0.000151	0.000166	CcSEcCtD
Pregabalin—Arthralgia—Methotrexate—urinary bladder cancer	0.000151	0.000166	CcSEcCtD
Pregabalin—Chest pain—Methotrexate—urinary bladder cancer	0.000151	0.000166	CcSEcCtD
Pregabalin—Tension—Doxorubicin—urinary bladder cancer	0.000151	0.000166	CcSEcCtD
Pregabalin—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000151	0.000166	CcSEcCtD
Pregabalin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.00015	0.000165	CcSEcCtD
Pregabalin—Malaise—Epirubicin—urinary bladder cancer	0.00015	0.000165	CcSEcCtD
Pregabalin—Discomfort—Methotrexate—urinary bladder cancer	0.00015	0.000164	CcSEcCtD
Pregabalin—Nervousness—Doxorubicin—urinary bladder cancer	0.00015	0.000164	CcSEcCtD
Pregabalin—Vertigo—Epirubicin—urinary bladder cancer	0.00015	0.000164	CcSEcCtD
Pregabalin—Syncope—Epirubicin—urinary bladder cancer	0.000149	0.000164	CcSEcCtD
Pregabalin—Leukopenia—Epirubicin—urinary bladder cancer	0.000149	0.000164	CcSEcCtD
Pregabalin—Back pain—Doxorubicin—urinary bladder cancer	0.000149	0.000164	CcSEcCtD
Pregabalin—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000148	0.000163	CcSEcCtD
Pregabalin—Palpitations—Epirubicin—urinary bladder cancer	0.000147	0.000162	CcSEcCtD
Pregabalin—Confusional state—Methotrexate—urinary bladder cancer	0.000146	0.000161	CcSEcCtD
Pregabalin—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000146	0.000161	CcSEcCtD
Pregabalin—Cough—Epirubicin—urinary bladder cancer	0.000145	0.00016	CcSEcCtD
Pregabalin—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000145	0.000159	CcSEcCtD
Pregabalin—Vision blurred—Doxorubicin—urinary bladder cancer	0.000145	0.000159	CcSEcCtD
Pregabalin—Convulsion—Epirubicin—urinary bladder cancer	0.000144	0.000158	CcSEcCtD
Pregabalin—Infection—Methotrexate—urinary bladder cancer	0.000144	0.000158	CcSEcCtD
Pregabalin—Nausea—Etoposide—urinary bladder cancer	0.000144	0.000158	CcSEcCtD
Pregabalin—Hypertension—Epirubicin—urinary bladder cancer	0.000144	0.000158	CcSEcCtD
Pregabalin—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000143	0.000157	CcSEcCtD
Pregabalin—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000142	0.000156	CcSEcCtD
Pregabalin—Anaemia—Doxorubicin—urinary bladder cancer	0.000142	0.000156	CcSEcCtD
Pregabalin—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000142	0.000156	CcSEcCtD
Pregabalin—Myalgia—Epirubicin—urinary bladder cancer	0.000142	0.000156	CcSEcCtD
Pregabalin—Arthralgia—Epirubicin—urinary bladder cancer	0.000142	0.000156	CcSEcCtD
Pregabalin—Chest pain—Epirubicin—urinary bladder cancer	0.000142	0.000156	CcSEcCtD
Pregabalin—Agitation—Doxorubicin—urinary bladder cancer	0.000142	0.000156	CcSEcCtD
Pregabalin—Anxiety—Epirubicin—urinary bladder cancer	0.000141	0.000155	CcSEcCtD
Pregabalin—Skin disorder—Methotrexate—urinary bladder cancer	0.000141	0.000155	CcSEcCtD
Pregabalin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000141	0.000155	CcSEcCtD
Pregabalin—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.00014	0.000154	CcSEcCtD
Pregabalin—Discomfort—Epirubicin—urinary bladder cancer	0.00014	0.000154	CcSEcCtD
Pregabalin—Malaise—Doxorubicin—urinary bladder cancer	0.000139	0.000153	CcSEcCtD
Pregabalin—Dry mouth—Epirubicin—urinary bladder cancer	0.000139	0.000152	CcSEcCtD
Pregabalin—Vertigo—Doxorubicin—urinary bladder cancer	0.000138	0.000152	CcSEcCtD
Pregabalin—Anorexia—Methotrexate—urinary bladder cancer	0.000138	0.000152	CcSEcCtD
Pregabalin—Syncope—Doxorubicin—urinary bladder cancer	0.000138	0.000152	CcSEcCtD
Pregabalin—Leukopenia—Doxorubicin—urinary bladder cancer	0.000138	0.000151	CcSEcCtD
Pregabalin—Confusional state—Epirubicin—urinary bladder cancer	0.000137	0.00015	CcSEcCtD
Pregabalin—Palpitations—Doxorubicin—urinary bladder cancer	0.000136	0.00015	CcSEcCtD
Pregabalin—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000136	0.000149	CcSEcCtD
Pregabalin—Oedema—Epirubicin—urinary bladder cancer	0.000136	0.000149	CcSEcCtD
Pregabalin—Hypotension—Methotrexate—urinary bladder cancer	0.000136	0.000149	CcSEcCtD
Pregabalin—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000135	0.000149	CcSEcCtD
Pregabalin—Infection—Epirubicin—urinary bladder cancer	0.000135	0.000148	CcSEcCtD
Pregabalin—Cough—Doxorubicin—urinary bladder cancer	0.000134	0.000148	CcSEcCtD
Pregabalin—Shock—Epirubicin—urinary bladder cancer	0.000134	0.000147	CcSEcCtD
Pregabalin—Convulsion—Doxorubicin—urinary bladder cancer	0.000133	0.000147	CcSEcCtD
Pregabalin—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000133	0.000146	CcSEcCtD
Pregabalin—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000133	0.000146	CcSEcCtD
Pregabalin—Hypertension—Doxorubicin—urinary bladder cancer	0.000133	0.000146	CcSEcCtD
Pregabalin—Tachycardia—Epirubicin—urinary bladder cancer	0.000133	0.000146	CcSEcCtD
Pregabalin—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000132	0.000145	CcSEcCtD
Pregabalin—Skin disorder—Epirubicin—urinary bladder cancer	0.000132	0.000145	CcSEcCtD
Pregabalin—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000131	0.000144	CcSEcCtD
Pregabalin—Insomnia—Methotrexate—urinary bladder cancer	0.000131	0.000144	CcSEcCtD
Pregabalin—Chest pain—Doxorubicin—urinary bladder cancer	0.000131	0.000144	CcSEcCtD
Pregabalin—Myalgia—Doxorubicin—urinary bladder cancer	0.000131	0.000144	CcSEcCtD
Pregabalin—Arthralgia—Doxorubicin—urinary bladder cancer	0.000131	0.000144	CcSEcCtD
Pregabalin—Anxiety—Doxorubicin—urinary bladder cancer	0.000131	0.000144	CcSEcCtD
Pregabalin—Paraesthesia—Methotrexate—urinary bladder cancer	0.00013	0.000143	CcSEcCtD
Pregabalin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.00013	0.000143	CcSEcCtD
Pregabalin—Discomfort—Doxorubicin—urinary bladder cancer	0.00013	0.000142	CcSEcCtD
Pregabalin—Anorexia—Epirubicin—urinary bladder cancer	0.00013	0.000142	CcSEcCtD
Pregabalin—Dyspnoea—Methotrexate—urinary bladder cancer	0.000129	0.000142	CcSEcCtD
Pregabalin—Somnolence—Methotrexate—urinary bladder cancer	0.000129	0.000142	CcSEcCtD
Pregabalin—Dry mouth—Doxorubicin—urinary bladder cancer	0.000128	0.000141	CcSEcCtD
Pregabalin—Hypotension—Epirubicin—urinary bladder cancer	0.000127	0.000139	CcSEcCtD
Pregabalin—Confusional state—Doxorubicin—urinary bladder cancer	0.000127	0.000139	CcSEcCtD
Pregabalin—Decreased appetite—Methotrexate—urinary bladder cancer	0.000126	0.000139	CcSEcCtD
Pregabalin—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000126	0.000138	CcSEcCtD
Pregabalin—Oedema—Doxorubicin—urinary bladder cancer	0.000126	0.000138	CcSEcCtD
Pregabalin—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000125	0.000138	CcSEcCtD
Pregabalin—Fatigue—Methotrexate—urinary bladder cancer	0.000125	0.000138	CcSEcCtD
Pregabalin—Infection—Doxorubicin—urinary bladder cancer	0.000125	0.000137	CcSEcCtD
Pregabalin—Pain—Methotrexate—urinary bladder cancer	0.000124	0.000136	CcSEcCtD
Pregabalin—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000124	0.000136	CcSEcCtD
Pregabalin—Shock—Doxorubicin—urinary bladder cancer	0.000124	0.000136	CcSEcCtD
Pregabalin—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000123	0.000135	CcSEcCtD
Pregabalin—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000123	0.000135	CcSEcCtD
Pregabalin—Insomnia—Epirubicin—urinary bladder cancer	0.000123	0.000135	CcSEcCtD
Pregabalin—Tachycardia—Doxorubicin—urinary bladder cancer	0.000123	0.000135	CcSEcCtD
Pregabalin—Skin disorder—Doxorubicin—urinary bladder cancer	0.000122	0.000134	CcSEcCtD
Pregabalin—Paraesthesia—Epirubicin—urinary bladder cancer	0.000122	0.000134	CcSEcCtD
Pregabalin—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000122	0.000134	CcSEcCtD
Pregabalin—Dyspnoea—Epirubicin—urinary bladder cancer	0.000121	0.000133	CcSEcCtD
Pregabalin—Somnolence—Epirubicin—urinary bladder cancer	0.000121	0.000133	CcSEcCtD
Pregabalin—Anorexia—Doxorubicin—urinary bladder cancer	0.00012	0.000132	CcSEcCtD
Pregabalin—Feeling abnormal—Methotrexate—urinary bladder cancer	0.00012	0.000131	CcSEcCtD
Pregabalin—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000119	0.00013	CcSEcCtD
Pregabalin—Decreased appetite—Epirubicin—urinary bladder cancer	0.000118	0.00013	CcSEcCtD
Pregabalin—Hypotension—Doxorubicin—urinary bladder cancer	0.000117	0.000129	CcSEcCtD
Pregabalin—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000117	0.000129	CcSEcCtD
Pregabalin—Fatigue—Epirubicin—urinary bladder cancer	0.000117	0.000129	CcSEcCtD
Pregabalin—Pain—Epirubicin—urinary bladder cancer	0.000116	0.000128	CcSEcCtD
Pregabalin—Constipation—Epirubicin—urinary bladder cancer	0.000116	0.000128	CcSEcCtD
Pregabalin—Urticaria—Methotrexate—urinary bladder cancer	0.000115	0.000127	CcSEcCtD
Pregabalin—Abdominal pain—Methotrexate—urinary bladder cancer	0.000115	0.000126	CcSEcCtD
Pregabalin—Body temperature increased—Methotrexate—urinary bladder cancer	0.000115	0.000126	CcSEcCtD
Pregabalin—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000115	0.000126	CcSEcCtD
Pregabalin—Insomnia—Doxorubicin—urinary bladder cancer	0.000114	0.000125	CcSEcCtD
Pregabalin—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000113	0.000124	CcSEcCtD
Pregabalin—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000112	0.000123	CcSEcCtD
Pregabalin—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000112	0.000123	CcSEcCtD
Pregabalin—Somnolence—Doxorubicin—urinary bladder cancer	0.000112	0.000123	CcSEcCtD
Pregabalin—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000111	0.000122	CcSEcCtD
Pregabalin—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000109	0.00012	CcSEcCtD
Pregabalin—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000109	0.000119	CcSEcCtD
Pregabalin—Fatigue—Doxorubicin—urinary bladder cancer	0.000108	0.000119	CcSEcCtD
Pregabalin—Urticaria—Epirubicin—urinary bladder cancer	0.000108	0.000119	CcSEcCtD
Pregabalin—Pain—Doxorubicin—urinary bladder cancer	0.000108	0.000118	CcSEcCtD
Pregabalin—Constipation—Doxorubicin—urinary bladder cancer	0.000108	0.000118	CcSEcCtD
Pregabalin—Body temperature increased—Epirubicin—urinary bladder cancer	0.000107	0.000118	CcSEcCtD
Pregabalin—Abdominal pain—Epirubicin—urinary bladder cancer	0.000107	0.000118	CcSEcCtD
Pregabalin—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000107	0.000118	CcSEcCtD
Pregabalin—Asthenia—Methotrexate—urinary bladder cancer	0.000104	0.000114	CcSEcCtD
Pregabalin—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000104	0.000114	CcSEcCtD
Pregabalin—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000103	0.000113	CcSEcCtD
Pregabalin—Pruritus—Methotrexate—urinary bladder cancer	0.000103	0.000113	CcSEcCtD
Pregabalin—Hypersensitivity—Epirubicin—urinary bladder cancer	0.0001	0.00011	CcSEcCtD
Pregabalin—Urticaria—Doxorubicin—urinary bladder cancer	9.99e-05	0.00011	CcSEcCtD
Pregabalin—Abdominal pain—Doxorubicin—urinary bladder cancer	9.94e-05	0.000109	CcSEcCtD
Pregabalin—Body temperature increased—Doxorubicin—urinary bladder cancer	9.94e-05	0.000109	CcSEcCtD
Pregabalin—Diarrhoea—Methotrexate—urinary bladder cancer	9.94e-05	0.000109	CcSEcCtD
Pregabalin—Asthenia—Epirubicin—urinary bladder cancer	9.75e-05	0.000107	CcSEcCtD
Pregabalin—Pruritus—Epirubicin—urinary bladder cancer	9.61e-05	0.000106	CcSEcCtD
Pregabalin—Dizziness—Methotrexate—urinary bladder cancer	9.6e-05	0.000105	CcSEcCtD
Pregabalin—Diarrhoea—Epirubicin—urinary bladder cancer	9.3e-05	0.000102	CcSEcCtD
Pregabalin—Hypersensitivity—Doxorubicin—urinary bladder cancer	9.26e-05	0.000102	CcSEcCtD
Pregabalin—Vomiting—Methotrexate—urinary bladder cancer	9.23e-05	0.000101	CcSEcCtD
Pregabalin—Rash—Methotrexate—urinary bladder cancer	9.16e-05	0.000101	CcSEcCtD
Pregabalin—Dermatitis—Methotrexate—urinary bladder cancer	9.15e-05	0.0001	CcSEcCtD
Pregabalin—Headache—Methotrexate—urinary bladder cancer	9.1e-05	9.99e-05	CcSEcCtD
Pregabalin—Asthenia—Doxorubicin—urinary bladder cancer	9.02e-05	9.91e-05	CcSEcCtD
Pregabalin—Dizziness—Epirubicin—urinary bladder cancer	8.99e-05	9.87e-05	CcSEcCtD
Pregabalin—Pruritus—Doxorubicin—urinary bladder cancer	8.9e-05	9.77e-05	CcSEcCtD
Pregabalin—Vomiting—Epirubicin—urinary bladder cancer	8.64e-05	9.49e-05	CcSEcCtD
Pregabalin—Nausea—Methotrexate—urinary bladder cancer	8.63e-05	9.47e-05	CcSEcCtD
Pregabalin—Diarrhoea—Doxorubicin—urinary bladder cancer	8.6e-05	9.45e-05	CcSEcCtD
Pregabalin—Rash—Epirubicin—urinary bladder cancer	8.57e-05	9.41e-05	CcSEcCtD
Pregabalin—Dermatitis—Epirubicin—urinary bladder cancer	8.56e-05	9.4e-05	CcSEcCtD
Pregabalin—Headache—Epirubicin—urinary bladder cancer	8.51e-05	9.35e-05	CcSEcCtD
Pregabalin—Dizziness—Doxorubicin—urinary bladder cancer	8.32e-05	9.13e-05	CcSEcCtD
Pregabalin—Nausea—Epirubicin—urinary bladder cancer	8.07e-05	8.87e-05	CcSEcCtD
Pregabalin—Vomiting—Doxorubicin—urinary bladder cancer	8e-05	8.78e-05	CcSEcCtD
Pregabalin—Rash—Doxorubicin—urinary bladder cancer	7.93e-05	8.71e-05	CcSEcCtD
Pregabalin—Dermatitis—Doxorubicin—urinary bladder cancer	7.92e-05	8.7e-05	CcSEcCtD
Pregabalin—Headache—Doxorubicin—urinary bladder cancer	7.88e-05	8.65e-05	CcSEcCtD
Pregabalin—Nausea—Doxorubicin—urinary bladder cancer	7.47e-05	8.2e-05	CcSEcCtD
